Hong Kong Suspends Pfizer-BioNTech Vaccine Use Over Packaging Defects
Officials said they had found no health risks, but the move deals a blow to the Chinese city’s already troubled inoculation campaign.
Officials said they had found no health risks, but the move deals a blow to the Chinese city’s already troubled inoculation campaign.
Officials said they had found no health risks, but the move deals a blow to the Chinese city’s already troubled inoculation campaign.
Officials said they had found no health risks, but the move deals a blow to the Chinese city’s already troubled inoculation campaign.
Syria’s economy in distress.
Syria’s economy in distress.
Syria’s economy in distress.
Syria’s economy in distress.
Syria’s economy in distress.
Syria’s economy in distress.
Shots: BioNTech and Fosun collaborated to supply 10M doses of their BNT162 mRNA-based vaccine candidate against COVID-19 to Hong Kong SAR and Macao SAR, once […]
TOKYO: Eisai Co., Ltd. announced today that the new drug application for approval of its in-house-discovered and developed orexin receptor antagonist DAYVIGO (generic name: lemborexant) […]
Copyright © 2024 | WordPress Theme by MH Themes